Kalpit Patel
Stock Analyst at Wolfe Research
(4.42)
# 1,186
Out of 4,596 analysts
220
Total ratings
38.9%
Success rate
16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CORT Corcept Therapeutics | Maintained: Sell | $50 | $114.49 | -56.33% | 4 | Jul 29, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $340 | $316.01 | +7.59% | 4 | Jul 1, 2026 | |
| GMAB Genmab | Maintained: Buy | $32 | $28.87 | +10.84% | 2 | Jun 14, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $35 | $27.18 | +28.77% | 1 | Jun 8, 2026 | |
| CGON CG Oncology | Maintained: Hold | n/a | $71.19 | - | 2 | May 26, 2026 | |
| CTMX CytomX Therapeutics | Initiated Coverage: Buy | $6 | $3.10 | +93.55% | 1 | May 19, 2026 | |
| MIRM Mirum Pharmaceuticals | Initiated Coverage: Buy | $145 | $105.95 | +36.86% | 1 | May 19, 2026 | |
| TYRA Tyra Biosciences | Initiated Coverage: Hold | n/a | $31.88 | - | 1 | May 19, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $165 | $187.53 | -12.01% | 1 | May 6, 2026 | |
| KRYS Krystal Biotech | Initiated Coverage: Hold | n/a | $341.12 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $11.45 | - | 1 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $16 | $5.80 | +175.86% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $29.82 | n/a | 2 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.33 | n/a | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $60 | $103.40 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $18.92 | n/a | 17 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $28 | $8.97 | n/a | 3 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $14 | $3.86 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $6.37 | n/a | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $24 | $36.81 | n/a | 10 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $29 | $19.05 | n/a | 9 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.5 → $2 | $1.29 | n/a | 33 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $4.53 | n/a | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $15 | $3.98 | n/a | 5 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $2.22 | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $1.88 | n/a | 14 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $0.6861 | n/a | 5 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $10.50 | n/a | 6 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $106.92 | n/a | 9 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.04 | n/a | 6 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.99 | n/a | 10 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $6 | $0.0127 | n/a | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $76.60 | n/a | 6 | Nov 26, 2021 |
Corcept Therapeutics
Jul 29, 2026
Maintained: Sell
Price Target: $50
Current: $114.49
Upside: -56.33%
BeOne Medicines AG
Jul 1, 2026
Maintained: Buy
Price Target: $340
Current: $316.01
Upside: +7.59%
Genmab
Jun 14, 2026
Maintained: Buy
Price Target: $32
Current: $28.87
Upside: +10.84%
Tango Therapeutics
Jun 8, 2026
Upgraded: Buy
Price Target: $35
Current: $27.18
Upside: +28.77%
CG Oncology
May 26, 2026
Maintained: Hold
Price Target: n/a
Current: $71.19
Upside: -
CytomX Therapeutics
May 19, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $3.10
Upside: +93.55%
Mirum Pharmaceuticals
May 19, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $105.95
Upside: +36.86%
Tyra Biosciences
May 19, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $31.88
Upside: -
Revolution Medicines
May 6, 2026
Maintained: Buy
Price Target: $165
Current: $187.53
Upside: -12.01%
Krystal Biotech
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $341.12
Upside: -
Mar 26, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $11.45
Upside: -
Oct 10, 2025
Reiterated: Buy
Price Target: $13 → $16
Current: $5.80
Upside: +175.86%
Jul 21, 2025
Maintained: Buy
Price Target: $37
Current: $29.82
Upside: n/a
Jun 16, 2025
Maintained: Buy
Price Target: $5
Current: $1.33
Upside: n/a
Jun 3, 2025
Upgraded: Buy
Price Target: $38 → $60
Current: $103.40
Upside: n/a
May 21, 2025
Reiterated: Hold
Price Target: $19
Current: $18.92
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $85 → $28
Current: $8.97
Upside: n/a
May 2, 2025
Maintained: Hold
Price Target: $17 → $14
Current: $3.86
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $9
Current: $6.37
Upside: n/a
Mar 5, 2025
Maintained: Hold
Price Target: $20 → $24
Current: $36.81
Upside: n/a
Mar 3, 2025
Maintained: Buy
Price Target: $36 → $29
Current: $19.05
Upside: n/a
Feb 26, 2025
Downgraded: Hold
Price Target: $3.5 → $2
Current: $1.29
Upside: n/a
Jan 29, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $4.53
Upside: n/a
Nov 18, 2024
Maintained: Hold
Price Target: $1 → $15
Current: $3.98
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $3
Current: $2.22
Upside: n/a
May 14, 2024
Maintained: Buy
Price Target: $10 → $7
Current: $1.88
Upside: n/a
Aug 14, 2023
Reiterated: Buy
Price Target: $12 → $14
Current: $0.6861
Upside: n/a
Mar 21, 2023
Maintained: Buy
Price Target: $7
Current: $10.50
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $106.92
Upside: n/a
Dec 30, 2022
Rated: Hold
Price Target: n/a
Current: $1.04
Upside: n/a
Aug 19, 2022
Rated: Hold
Price Target: n/a
Current: $2.99
Upside: n/a
Jun 7, 2022
Maintained: Buy
Price Target: $12 → $6
Current: $0.0127
Upside: n/a
Nov 26, 2021
Rated: Hold
Price Target: n/a
Current: $76.60
Upside: n/a